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Maternal and child cytokine relationship in early life is not
altered by cytokine gene polymorphisms
Y Djuardi1,2, T Supali1, H Wibowo1, BT Heijmans3, J Deelen3, EP Slagboom3, JJ Houwing-Duistermaat4, E Sartono2 and
M Yazdanbakhsh2
The development of immune responses is inﬂuenced by the interaction between environmental and genetic factors. Our previous
study showed a close association between maternal and young infant’s cytokine responses. The question is how this association
evolves over time and the contribution of genetic polymorphisms to this association. Five cytokines in mitogen-stimulated whole
blood culture were measured from pregnant mothers and their children aged 2, 5, 12, 24 and 48 months. Cytokine gene
polymorphisms were determined in both mothers and children. High production of maternal interleukin (IL)-10, tumour necrosis
factor-α (TNF-α) and interferon-γ (IFN-γ) was signiﬁcantly associated with higher levels of the corresponding cytokines in their
children at 2 months (T2), but the association decreased over time. Maternal single-nucleotide polymorphism (SNP) in IFN-γ gene,
rs3181032, was found to be associated with child’s IFN-γ levels at T2 only, whereas maternal IL-10 rs4579758 and child’s TNF-α
rs13215091 were associated with child’s corresponding cytokines at later ages but not at T2. In the ﬁnal models including the gene
polymorphisms, maternal cytokines were still the strongest determinant of child cytokines. Maternal cytokine during pregnancy,
which could be a proxy for child’s environmental factors, showed its highest impact at early age, with no or little inﬂuence from
genetic factors.
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INTRODUCTION
There has been an increasing number of studies looking at
immune responses in early life and its modulation by environ-
mental factors, which may predispose an individual to certain
diseases in later life. Several studies have shown parallels in
cellular immune responses between mothers and their children.1–5
The mechanisms behind this have not been elucidated. Moreover,
all these studies were conducted in developed countries, where
infectious diseases are better controlled, while allergic and
autoimmune diseases are increasingly affecting the population.6
Speciﬁcally, the relationship between in utero exposure, early
immune proﬁles after birth and the development of immune
responses in early childhood has not been examined comprehen-
sively in populations where chronic parasitic infections are
endemic. In this regard, our previous study in a helminth-
endemic area found that maternal cytokines (interleukin (IL)-10
and interferon-γ (IFN-γ)) were associated with infant’s cytokines at
the age of 2 months, even after taking into account several
environmental factors including maternal parasitic infections,7 in
agreement with the ﬁndings from the studies in industrialized
countries where maternal and child cytokine responses appear to
be tightly linked.1–5
Interaction between environment and genetic factors will
determine the phenotypic outcome of an individual. To our
knowledge, there has been no study looking at the changing
pattern of the mother–child cytokine relationship over time and
whether genetic factors can modify this relationship. To investi-
gate this, we measured child’s cytokine responses to mitogen at
ﬁve time points, starting around 2 months and up to 4 years of
age, and examined the relationship with maternal cytokine
responses during pregnancy. We genotyped single-nucleotide
polymorphisms (SNPs) from mothers and children and asked
whether they modiﬁed the cytokine relationship of mother
and child.
RESULTS
Characteristics of mother–child pairs
The ﬂow diagram of the entire study is described elsewere.8 We
included 119 mothers and children in the present study, with 54%
(64/119) children being males. Among 107 children with data on
breastfeeding, 83 children (78%) received breastfeeding exclu-
sively for 6 months, followed by 21 (19%) children who were
partially breastfed (mixed with formula milk) and 3 (3%) children
who were not breastfed. Although all 119 mother and child pairs
had genotype data, the number of children with cytokine data
was different at each time point: 111 at T2, 95 at T5, 90 at T12, 88
at T24 and 86 at T48. The median maternal cytokine levels in
response to phytohaemmaglutinin (PHA) were used to classify a
mother as a high or low cytokine producer (see legend to
Figure 1).
Minor allele frequency and P-values for testing the null hypothesis
that Hardy–Weinberg equilibrium holds for all SNPs of the mother–
child pairs are shown in the Supplementary Table S1. All genotyped
SNPs were in Hardy–Weinberg equilibrium with the exception of
the two IL-5 gene polymorphisms, rs4143832 and rs17690122
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(both in perfect linkage disequilibrium (LD)/r2 = 1), which slightly
deviated from Hardy–Weinberg equilibrium (P= 0.039). The other
SNPs that showed perfect LD were rs1878672 and rs1800896 in
IL-10 gene. Several SNPs were in high LD (r240.8), such as
between rs10494879 and rs1878672 or rs1800896 in the IL-10
gene, between rs10878763 and rs10784683 in the IFN-γ gene,
between rs2040704 in RAD50 gene and rs1800925 in IL-13 gene,
between rs1881457 and rs1800925, and between rs1295686 and
rs20541 in IL-13 gene (Supplementary Table S1). Altogether, there
were six pairs of SNPs in perfect LD or high LD, which caused
similar results in the analyses.
Association between maternal and child cytokines over time
Table 1 shows that high cytokine producer mothers were
associated with higher child cytokine production in response to
PHA at 2 months of age (T2), this is true for IL-10 (estimate: 0.31;
95% conﬁdence interval (95% CI): 0.19, 0.43), IFN-γ (estimate: 0.26;
95% CI: 0.03, 0.49) and, to a lesser extent, for tumour necrosis
factor-α (TNF-α; estimate: 0.19; 95% CI: 0.02, 0.36). With increasing
age, the mother–child relationship for IL-10 disappeared (interac-
tion between maternal IL-10 with time, P= 0.002), whereas for
TNF-α and IFN-γ the relationship did not change signiﬁcantly. The
production of TH2-type cytokines, IL-5 and IL-13, were not
signiﬁcantly associated between mother and child at baseline or
over time (Table 1).
Association between maternal cytokines or genetic factors and
child’s cytokines over time
IL-10 and TNF-α. The estimated effect of maternal IL-10 and
maternal or child’s genotype on child’s IL-10 production in
response to PHA is shown in Table 2. Here, only genotypes that
revealed signiﬁcant associations are presented. In this model, at
2 months of age the estimates for mother–child cytokine
relationship were similar to the estimates in the previous model
without genetic factors (Table 2 and Figure 1a; estimate: 0.31; 95%
CI: 0.18, 0.43), indicating that the variants tested here did not
explain the relationship between maternal and child cytokines.
Figure 1. Child’s PHA-induced cytokines over time, based on maternal cytokine producer status during pregnancy. Error bars represent
geometric means of (a) IL-10, (b) TNF-α, (c) IFN-γ, (d) IL-5 levels and mean of square of (e) IL-13 levels of children at the age of 2 months (T2),
5 months (T5), 12 months (T12), 24 months (T24) and 48 months (T48). Closed dots are children born to high producer mothers, whereas
open dots are children born to low producer mothers. The median of maternal cytokines is used to divide high or low producer mothers: IL-10
(91.7, interquartile range (IQR): 46.9–167.1 pg ml− 1), TNF-α (274.2, IQR: 54.7–915.6 pg ml− 1), IFN-γ (152.5, IQR: 43.7–425.5 pg ml− 1), IL-5 (859.8,
IQR: 295.0–1673.8 pg ml− 1) and IL-13 (243.5, IQR: 75.7–627.2 pg ml− 1). All values were adjusted for mother and child’s gene polymorphism,
village of residence and child’s gender.
Table 1. Effect of maternal cytokine on child’s cytokine production
over time
Estimate (95% CI)a P-value
IL10
Maternal cytokine 0.31 (0.19, 0.43) o0.0001
Time maternal cytokineb − 0.009 (−0.01, − 0.003) 0.002
TNF-α
Maternal cytokine 0.19 (0.02, 0.36) 0.030
Time maternal cytokineb − 0.006 (−0.01, 0.002) 0.146
IFN-γ
Maternal cytokine 0.26 (0.03, 0.49) 0.027
Time maternal cytokineb − 0.009 (−0.02, 0.002) 0.093
IL-5
Maternal cytokine 1.51 (−2.58, 5.60) 0.466
Time maternal cytokineb 0.15 (−0.04, 0.34) 0.121
IL-13
Maternal cytokine 0.07 (−0.08, 0.23) 0.348
Time maternal cytokineb 0.0002 (−0.008, 0.009) 0.954
Abbreviations: CI, conﬁdence interval; IFN-γ, interferon-γ; IL, interleukin;
TNF-α, tumor necrosis factor-α. The estimates shows associations between
maternal and child’s cytokines at 2 months of age. Bold P-value o0.05.
aAdjusted for child gender. bInteraction between time and maternal
cytokine, showing the change of association between maternal and child’s
cytokines over time. Time units are 2, 5, 12, 24 and 48 months.
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In contrast to maternal cytokine status, neither maternal nor
child’s IL-10 genotypes were associated with child’s cytokine at T2.
However, at later time points we observed a tendency for children
born to mothers with more G allele in rs4579758 to have
signiﬁcantly higher production of IL-10 over time (Table 2 and
Figure 2a). When formally tested in a dominant model, the
contribution of maternal genotype at this locus on the child’s IL-10
levels over time was signiﬁcant. However, the child’s genotype
had no effect on IL-10 production over time.
In a similar manner to IL-10 but weaker, the production of the
child’s PHA-induced TNF-α at 2 months of age was associated with
maternal TNF-α production (Table 2 and Figure 1b; estimate: 0.20,
95% CI: 0.03, 0.37) and this association decreased over time.
Although at the beginning there was a positive trend for
association between polymorphism of child’s rs13215091 and
TNF-α levels (estimate: 0.17; 95% CI: − 0.02, 0.37), the direction of
association reversed over time with signiﬁcantly stronger effect
exerted by child’s decreasing number of minor allele (estimate:
− 0.01; 95% CI: − 0.02, − 0.004; Table 2 and Figure 2b). For the
other three SNPs of TNF-α, maternal and child’s genotype did not
show signiﬁcant associations with child’s cytokine at baseline and
over time (data not shown).
IFN-γ, IL-5 and IL-13. The production of TH1-type responses (IFN-γ)
in response to PHA in children after adjustment for genotypes was
associated with maternal cytokine producer status at baseline
(Table 2 and Figure 1c; estimate: 0.26; 95% CI: 0.04, 0.48) and this
association did not change over time (estimate: − 0.009; 95% CI:
− 0.02, 0.001). Among six IFN-γ polymorphisms, the only genotype
found to be signiﬁcantly associated with child’s cytokine was
rs3181032 of mother, which is an IFN-γ gene polymorphism
located in the promoter region. Mothers with increasing number
of this SNP’s minor allele were more likely to have children
producing lower IFN-γ levels at T2 (Table 2 and Figure 2c; estimate:
− 0.30; 95% CI: − 0.58, − 0.01); however, over time the direction of
the association reversed (estimate: 0.01; 95% CI: 0.002, 0.03).
Among all genotyped IL-5 SNPs, only two of child’s IL-5
polymorphisms, rs4143832 and rs739719, were associated with
child’s cytokine production at T2 (Table 2 and Figure 2d and e;
estimate: − 4.93; 95% CI: − 9.60, − 0.27 and estimate: 4.17; 95% CI:
0.12, 8,23, respectively) with no signiﬁcant difference of slopes
with time. None of IL-13 or RAD50 gene polymorphisms were
associated with child’s IL-13 or with IL-5 and IL-13 levels,
respectively (data not shown).
DISCUSSION
Our study is the ﬁrst to examine longitudinally, at ﬁve different
time points from 6 weeks to 4 years of age, the association
between cytokine production of a pregnant mother and her child
in Indonesia, a developing country. In the present study, we show
that a number of variants tested at cytokine candidate genes do
not explain the strong association between maternal cytokine
production during pregnancy with child’s cytokine production in
the ﬁrst year of life. We also found that most of the mother–child
cytokine relationships became weaker over time (IL-10, IFN-γ and
TNF-α). These ﬁndings indicate that the strong association
between cytokine responses of a pregnant mother and her child
is not directly due to genetic factors but could likely result from
similar immune conditioning during gestational period extending
Table 2. Effect of maternal cytokine, maternal and child’s genotype on child’s PHA-induced cytokine production over time
Child cytokine Variable Estimate (95% CI)a P-value
IL10 Maternal cytokine 0.31 (0.18, 0.43) o0.0001b
rs4579758 Maternal genotype − 0.05 (−0.16, 0.05) 0.321
Child’s genotype − 0.009 (−0.11, 0.10) 0.866
Time maternal cytokinec − 0.008 (−0.01, − 0.003) 0.004
Time maternal genotypec 0.005 (0.0002, 0.01) 0.039
Time child’s genotypec 0.001 (−0.003, 0.006) 0.616
TNF-α Maternal cytokine 0.20 (0.03, 0.37) 0.024
rs13215091 Maternal genotype − 0.005 (−0.21, 0.20) 0.961
Child’s genotype 0.17 (−0.02, 0.37) 0.080
Time maternal cytokinec − 0.006 (−0.01, 0.001) 0.108
Time maternal genotypec 0.004 (−0.005, 0.01) 0.354
Time child’s genotypec − 0.01 (−0.02, − 0.004) 0.005
IFN-γ Maternal cytokine 0.26 (0.04, 0.48) 0.023
rs3181032 Maternal genotype − 0.30 (−0.58, − 0.01) 0.039
Child’s genotype 0.26 (−0.10, 0.61) 0.152
Time maternal cytokinec − 0.009 (−0.02, 0.001) 0.077
Time maternal genotypec 0.01 (0.002, 0.03) 0.024
Time child’s genotypec − 0.0008 (−0.02, 0.01) 0.919
IL-5 Maternal cytokine 1.46 (−2.59, 5.51) 0.476
Rs4143832 Maternal genotype 4.32 (−1.27, 9.91) 0.129
Child’s genotype − 4.93 (−9.60, − 0.27) 0.038
Time maternal cytokinec 0.17 (−0.02, 0.36) 0.075
Time maternal genotypec − 0.24 (−0.49, 0.02) 0.066
Time child’s genotypec 0.14 (−0.08, 0.35) 0.210
IL-5 Maternal cytokine 1.02 (−3.07, 5.10) 0.622
Rs739719 Maternal genotype − 2.10 (−5.76, 1.56) 0.259
Child’s genotype 4.17 (0.12, 8.23) 0.044
Time maternal cytokinec 0.14 (−0.05, 0.34) 0.143
Time maternal genotypec − 0.02 (−0.19, 0.15) 0.799
Time child’s genotypec − 0.02 (−0.21, 0.17) 0.849
Abbreviations: CI, conﬁdence interval; IFN-γ, interferon-γ; IL, interleukin; TNF-α, tumor necrosis factor-α. Time units are 2, 5, 12, 24 and 48 months. Bold
P-values o0.05. The estimates shows associations between maternal cytokines or genotypes and child’s genotypes at with child’s cytokine production at
2 months of age. aAdjusted for child gender. bSigniﬁcant after Bonferroni’s correction (Po0.0028). cInteraction between time and maternal cytokine/genotype
or child’s genotype, showing the change of association between maternal cytokine/genotype or child’s genotype with child’s cytokine production over time.
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into early childhood. This was different for IL-5. The association
between maternal and child IL-5 production, which was not
signiﬁcant in the ﬁrst 2 years of age, became signiﬁcant when the
child reached 4 years of age.
Earlier studies had found associations in cytokine production
between mother (pre- or postpartum) and child at one or two time
points, such as at birth in cord blood,1,2,5 at a time when infant
was 3 months,3 1 year5,9 or 2 years of age.4 The mother–child
cytokine relationship was not always apparent directly after birth.
For example, the birth cohort study by Halonen et al.3 showed no
correlation of mitogen-stimulated IFN-γ and IL-13 between a
pregnant mother and fetus, but instead with the child at 3 months
of age. Similarly, in another study with the lipopolysaccharide-
induced IL-10 and TNF-α production, there was a signiﬁcant
association between pregnant mother and the child at the age of
1 year but not with cord blood.9 Our results are in agreement with
the previous two studies in that maternal IL-10 or IFN-γ production
during pregnancy was positively associated with child’s corre-
sponding cytokines up to 1 year of age but with longer
observation, the association was no longer present (Figure 1).
This particular ﬁnding regarding IL-10 or IFN-γ may reﬂect intra
uterine and nursing effect on child’s developing immune system.
Although no trans-placental transfer of maternal cytokines in
humans are believed to occur,10 the components of uterine
microenvironment may modulate the fetal naive immune cells.
This might explain why maternal IL-10 during pregnancy showed
the strongest association with child’s IL-10. After birth, the
maturating immune system of infants is believed to get
compensations from breast milk, which contains maternal
humoral and cellular immune components including cytokines,
chemokines and immune cells. As the majority (97%) of the
infants/children in our study was breastfed, breast milk may also
contribute to the transfer of maternal immunological information
to infants in this population. Both IL-10 and IFN-γ are present in
breast milk11,12 In the case of IL-10 this is thought to be a
continuation of immune regulation during gestation, to avoid
rejection of fetal allograft, whereas for IFN-γ the nursing can be
the best way to complement the infant’s immune system whose
capacity to produce TH1-type responses are less than in adults.
13
Interestingly, high levels of TNF-α are present in early milk but
become almost undetectable after 1 month, whereas IL-10, IFN-γ,
IL-5 and IL-13 tend to maintain certain levels in mature milk
(reviewed in Agarwal et al.12). This might explain the weak
association we observed in TNF-α production between mother
and child in the ﬁrst year of life.
The pattern of mother–child relationship in IL-5 responses was
different from other cytokines, in that the signiﬁcant association
was found only when the children reached 4 years of age. There
are no other studies examining IL-5 in this context and one
possibility to explain our observation might be the fact that the
study area is endemic for helminth infections. As children grow
older they increasingly become infected with helminths,14 which
drive TH2 responses, and therefore the closer association between
maternal and child IL-5 at 4 years of age might reﬂect the sharing
of helminth-infected environment with the mother.
It appears that at early age, the capacity of infant’s immune cells
to produce pro- and anti-inﬂammatory cytokines (TNF and IL10,
respectively) is more inﬂuenced by maternal cytokines than by the
genetic variation tested, which seem to have more inﬂuence at
later age. On the other hand, we found that the production of TH1-
type cytokine at early age was independently associated with
maternal cytokine and gene polymorphisms. Previous studies in
adult twins showed that cytokines can have a low to high
proportion of heritability, ranging from 30 to 75% for IL-10,15–17
40 to 85% for IFN-γ15,18 and 17 to 80% for TNF-α.15–19 The
participants of these studies were adults. Our cohort study is
unique in showing the effect of maternal cytokines on child
cytokines in early age may overrule or mask the genetic effect
during the maturation of child immune responses. This notion is
supported by the ﬁnding in a twin study, which showed that the
genetic effect on serum TNF-α increased with age.17 In the case of
IL-10, at the later age (T48), when the association with maternal
cytokine weakened, the pattern of IL-10 production from children
born to rs4579758-AA mothers did not increase as much as those
Figure 2. Child’s PHA-induced cytokines over time, based on maternal or child genotypes. Only SNPs that showed signiﬁcant associations in
the multivariate models are shown. Error bars represent geometric means of (a) IL-10, (b) TNF-α, (c) IFN-γ and (d and e) IL-5 levels of children at
the age of 2 months (T2), 5 months (T5), 12 months (T12), 24 months (T24) and 48 months (T48). Red dots/interrupted lines indicate the
children having or born to mothers with major homozygote alleles, whereas black dots/solid lines for heterozygotes and blue dots and solid
lines for minor homozygotes. All values were adjusted for maternal cytokines, village of residence and child’s gender.
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born to AG/GG mothers. It is known that a child inherits half
maternal genes; therefore, it is not necessary that the child will
have the same alleles as the mother. On the other hand, there
were several studies showing that maternal gene polymorphisms
may affect child’s response through non-genetic factor, but
epigenetic programming via exposure of child in utero or early
life to maternal cytokines. The function of child’s cytokine gene
polymorphism may appear later in life, which may overcome the
weakening impact of maternal cytokine. The fact that in the
present study maternal genotype contributed more to child’s IL-10
production than the child’s own genotype may indicate that
maternal genetic factors could have their effect on child’s
cytokines not necessarily through genetic inheritance but through
interaction with the environmental factors (epigenetic program-
ming), via in utero effects, and/or breastfeeding. Indeed, previous
studies found such interactions between maternal genotype and
environment on child’s immune outcomes.20
Regarding the IL-10 SNP of mother (rs4579758) that showed
signiﬁcant association with child’s cytokine, so far no other studies
have shown any functional consequences of this SNP in
association with cytokine production or disease. Nevertheless,
this SNP was found in high LD (r2 = 0.97 for Asian) with another
SNP, rs6692511. The latter SNP is located in the site of DNase I
hypersensitivity clusters and transcription factors, which are
associated with regulation of gene expression (http://genome-
euro.ucsc.edu) and therefore could contribute to our observation
regarding IL-10.
It is important to note that the nonsigniﬁcant associations
between child cytokine production with SNPs detected in this
study might also be caused by other unmeasured SNPs that were
located in a larger distance but still in LD. We realize that using
single-nucleotide analysis in this study may not entirely represent
the genetic effect on child’s cytokine responses, as there are
unmeasured genetic variations besides the measured SNPs, which
may reveal a cytokine relationship between mother and child,
such as copy number variation, haplotype, microsatellite alleles as
well as epigenetic processes (DNA methylation, histone modiﬁca-
tions and small non-coding RNA). Nevertheless, using the tagging
SNPs we expected to limit the number of SNPs to be tested by
covering those not genotyped, which were in high LD with the
tagging SNPs in the same gene.21
As the aim of the study was more focused on mother–child
cytokine relationship, we consider the SNP analysis in relation to
the child’ cytokine responses exploratory. Therefore, the weak
associations (Po0.05) found between genotypes and cytokine
production before correction for multiple testing were not
considered immediately as not signiﬁcant. The conﬁrmation of
the gene association results would need replication with larger
sample size in similar population/race. It would also be interesting
to investigate whether the effect of gene polymorphism seen at 4
years of age will be maintained at older age; for example, the
children born to mothers with AA genotype of rs4579758 will
continue to have a stabile lower IL-10 production compared with
those born to AG/GG mothers or will they eventually catch up.
In conclusion, the close relationship of mother and child
cytokine production, especially IL-10 and IFN-γ, was prominent in
early life, before 1 year of age. This immunological relationship
appeared to be independent of cytokine gene polymorphisms,
suggesting that infant’s cytokine responses were more inﬂuenced
by the environment shared with the mother during intra uterine
and breastfeeding period. Different cytokines can have different
interaction with maternal cytokine and maternal/child genetic
factors at certain time points, depending on the maturation of
child immune responses and the challenges from the environ-
ment. Furthermore, whether the cytokine proﬁle of children born
to high or low producer mother is associated with clinical
outcomes or only reﬂects physiological variation needs to be
investigated.
SUBJECTS AND METHODS
Study population
This study is part of the longitudinal study of children living in a peri-urban
area in Bekasi Distric, West Java province, Indonesia. Children were followed
up at ﬁve time points: 2 (T2), 5 (T5), 12 (T12), 24 (T24) and 48 (T48) months of
age. Among all participants, there were 126 pairs of pregnant mothers in
second or third trimester and their children who had both cytokine
measurements and genotyping data. All mothers provided written informed
consent for themselves and their children. This study was approved by the
Ethical Committee Faculty of Medicine Universitas Indonesia.
Whole-blood culture and cytokine measurement
Whole-blood culture and cytokine measurement were performed as
described previously.7 Brieﬂy, heparinized venous blood was diluted 1:10
with RPMI-1640 medium (added with 1 mM pyruvate and 2 mM glutamate),
followed by incubation with PHA (2 μg ml− 1; Wellcome Diagnostics,
Dartford, UK) in 37 °C and 5% CO2. The concentrations of IL-10 and TNF-α
were measured in day 1 supernatant, whereas IL-5, IL-13 and IFN-γ were
measured in day 6 supernatant. Supernatants were kept frozen at − 20 °C
and later on were thawed for the measurement with in-house multiplex
bead-based assay (Luminex IS 100, Luminexcorp, Austin, TX, USA) for IL-10,
TNF-α, IL-13 and IFN-γ, whereas enzyme-linked imminosorbent assay was
performed for measurement of IL-5. The detection limits for IL-10, TNF-α,
IL-13, IFN-γ and IL-5 were 6.5, 1.7, 12.5, 3.6 and 2 pg ml− 1, respectively. All
cytokine levels below detection limit were given half of the threshold value.
DNA puriﬁcation and genotyping
Genomic DNA was puriﬁed from 200 μl of whole-blood samples from
pregnant mothers and their children, which was kept frozen at − 20 °C,
using QIAamp DNA Mini kit (Qiagen, Hilden, Germany) according to the
manufacturer’s protocol. The puriﬁed DNA was quantiﬁed using NanoDrop
1000 Spectrophotometer (Thermo Scientiﬁc, Wilmington, DE, USA).
The source of cytokine gene polymorphisms for Indonesians living in
West Java were derived from Malays population in Singapore Variation
Genome Project database (http://www.statgen.nus.edu.sg/ ~ SGVP),22 with
some additional SNPs, which were not found in the database but were
associated with phenotypes in Asian or other populations. A set of gene
polymorphisms spanning from 20 kb upstream and 10 kb downstream
from each cytokine gene region were included in the genotyping. Pairwise
tagging SNPs were obtained from Haploview’s Tagger program (http://
www.broad.mit.edu/mpg/tagger), with selection based on minor allele
frequency ⩾5% and r2 threshold= 0.8. All SNPs selected with this method
were included in the analysis, including those SNPs that have not been
found to be functional or associated with diseases.
In total, there were 10 SNPs for IL-10, 4 SNPs for TNF-α, 6 SNPs for IFN-γ, 6
SNPs for IL-5 and 8 SNPs for IL-13. In addition to these cytokine genes, 4 SNPs
of RAD50 genes were added, as they occupy the region between IL-4, IL-5 and
IL-13 genes (TH2 cytokine locus) in chromosome 5q31. RAD50 gene encodes a
DNA repair enzyme; it was recently found to have locus control region at its
3′-end and is shown to be associated with asthma and eczema.23,24
Genotyping of all SNPs were performed using Sequenom MassARRAY iPLEX
Platform (Sequenom, Inc., CA, USA). Quality control was performed by
including ±10% of successfully genotyped samples and positive controls in
the repeated measurement of failed samples. At the end, all SNPs were
genotyped successfully with call rates ⩾90%. After exclusion of two mother–
child pairs, who had call rates o95%, and ﬁve pairs with Mendelian
inconsistencies, data were available for a total of 119 pairs.
Statistical analysis
Cytokine levels displayed skewed distributions, therefore log (base 10)
transformation was used for all cytokines, except for IL-5, for which a
square-root transformation was used. To investigate the association
between mother and child’s cytokine productions, we divided maternal
cytokines based on median levels into high or low producer mothers7 and
by using this category we compared child cytokine levels at each time
point. Minor allele frequency, deviations from Hardy–Weinberg equilibrium
and pairwise LD were calculated for each mother or child’s SNP using
Haploview software (http://www.broadinstitute.org).
First, we modeled the association between maternal cytokines and child
cytokines. Next, we modeled the maternal cytokines together with
maternal or child genotype. We used linear mixed models to study the
effect of maternal cytokines and maternal or child genotypes over time on
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child cytokines. Using a likelihood ratio test, we tested whether the simpler
ﬁrst-order autoregressive heterogenous (for IL-10 and TNF-α) structrure
could be used to model correlation over time instead of the unstructured
(for IFN-γ, IL-5 and IL-13) covariance structure. Each genotype was coded 0,
1 and 2 for the increasing number of minor alleles and all SNPs were tested
using an additive genetic model. First, we used model with main effects
and one interaction term between time and SNP (that is, linear change
over time) for all SNPs. For signiﬁcant SNPs, we continued with a larger
model where time was included as a categorical variable to obtain more
insight of the effect of the SNP over time. Bonferroni corrections were
done for multiple testing, where a P-value was considered signiﬁcant if
o0.0028. All models were adjusted for child gender as an a priori factor for
child’s cytokine responses.15 The statistical analyses were performed using
IBM SPSS version 20 (International Business Machines Corporation,
Chicago, IL, USA).
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